UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 82

Sortiert nach

Expansion of the target of rapamycin (TOR) kinase family and function in Leishmania shows that TOR3 is required for acidocalcisome biogenesis and animal infectivity

Proceedings of the National Academy of Sciences - PNAS, 2010-06, Vol.107 (26), p.11965-11970

2010

Volltextzugriff (PDF)

Interplay between Immune Checkpoint Proteins and Cellular Metabolism

Cancer research (Chicago, Ill.), 2017-03, Vol.77 (6), p.1245-1249

2017

Volltextzugriff (PDF)

Regulated expression of the Leishmania major surface virulence factor lipophosphoglycan using conditionally destabilized fusion proteins

Proceedings of the National Academy of Sciences - PNAS, 2009-05, Vol.106 (18), p.7583-7588

2009

Volltextzugriff (PDF)

ALDH1A1 maintains ovarian cancer stem cell-like properties by altered regulation of cell cycle checkpoint and DNA repair network signaling

PloS one, 2014-09, Vol.9 (9), p.e107142

2014

Volltextzugriff (PDF)

Clinicopathologic significance and race-specific prognostic association of MYB overexpression in ovarian cancer

Scientific reports, 2021-06, Vol.11 (1), p.12901-12901, Article 12901

2021

Volltextzugriff (PDF)

The susceptibility of trypanosomatid pathogens to PI3/mTOR kinase inhibitors affords a new opportunity for drug repurposing

PLoS neglected tropical diseases, 2011-08, Vol.5 (8), p.e1297

2011

Volltextzugriff (PDF)

Associations between DNA Damage and PD-L1 Expression in Ovarian Cancer, a Potential Biomarker for Clinical Response

Biology (Basel, Switzerland), 2021-04, Vol.10 (5), p.385

2021

Volltextzugriff (PDF)

ENTPD1/CD39 as a predictive marker of treatment response to gemogenovatucel-T as maintenance therapy in newly diagnosed ovarian cancer

Communications medicine, 2022-08, Vol.2 (1), p.106-9, Article 106

2022

Volltextzugriff (PDF)

Immunoregulatory Protein B7-H3 Reprograms Glucose Metabolism in Cancer Cells by ROS-Mediated Stabilization of HIF1α

Cancer research (Chicago, Ill.), 2016-04, Vol.76 (8), p.2231-2242

2016

Volltextzugriff (PDF)

Analysis of the COVID-19 Vaccine Development Process: an Exploratory Study of Accelerating Factors and Innovative Environments

Journal of pharmaceutical innovation, 2021-02, Vol.17 (2), p.555-571

2021

Volltextzugriff (PDF)

Unraveling the etiology of ovarian cancer racial disparity in the deep south: Is it nature or nurture?

Gynecologic oncology, 2017-05, Vol.145 (2), p.329-333

2017

Volltextzugriff (PDF)

The Landscape of Neutralizing Monoclonal Antibodies (nAbs) for Treatment and Prevention of COVID-19

Journal of pharmaceutical innovation, 2023-09, Vol.18 (3), p.1194-1212

2023

Volltextzugriff (PDF)

Phosphodiesterase 10A is overexpressed in lung tumor cells and inhibitors selectively suppress growth by blocking β-catenin and MAPK signaling

Oncotarget, 2017-09, Vol.8 (41), p.69264-69280

2017

Volltextzugriff (PDF)

Suppression of Colon Tumorigenesis in Mutant Apc Mice by a Novel PDE10 Inhibitor that Reduces Oncogenic β-Catenin

Cancer prevention research (Philadelphia, Pa.), 2021-11, Vol.14 (11), p.995-1008

2021

Volltextzugriff (PDF)

Phosphodiesterase 10A (PDE10A) as a novel target to suppress β-catenin and RAS signaling in epithelial ovarian cancer

Journal of ovarian research, 2022-11, Vol.15 (1), p.120-17, Article 120

2022

Volltextzugriff (PDF)

Prospects and Trends in the Brazilian Market for Biologically Sourced Products

Journal of technology management & innovation, 2012-10, Vol.7 (3), p.44-56

2012

Volltextzugriff (PDF)

Long-Term Follow-Up of Gemogenovatucel-T (Vigil) Survival and Molecular Signals of Immune Response in Recurrent Ovarian Cancer

Vaccines (Basel), 2021-08, Vol.9 (8), p.894

2021

Volltextzugriff (PDF)

DNA damage measurements within tissue samples with Repair Assisted Damage Detection (RADD)

Current research in biotechnology, 2019-11, Vol.1, p.78-86

2019

Volltextzugriff (PDF)

Author Correction: ENTPD1/CD39 as a predictive marker of treatment response to gemogenovatucel-T as maintenance therapy in newly diagnosed ovarian cancer

Communications medicine, 2023-05, Vol.3 (1), p.63-1, Article 63

2023

Volltextzugriff (PDF)

RAD6 promotes DNA repair and stem cell signaling in ovarian cancer and is a promising therapeutic target to prevent and treat acquired chemoresistance

Oncogene, 2017-11, Vol.36 (48), p.6680-6690

2017

Volltextzugriff (PDF)

Associations between DNA damage and PDL‐1 expression in ovarian cancer, a potential biomarker for clinical response

The FASEB journal, 2021-05, Vol.35 (S1), p.n/a, Article fasebj.2021.35.S1.05041

2021

Volltextzugriff (PDF)

Mutagenesis and analysis of genetic mutations in the GC-rich KISS1 receptor sequence identified in humans with reproductive disorders

Journal of visualized experiments, 2011-09 (55), p.e2897

2011

Volltextzugriff (PDF)

A plasma-based analysis and genomic landscape of patients with high tumor mutational burden (TMB-H), microsatellite stable (MSS) colorectal cancer (CRC)

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.249-249

2023

Volltextzugriff (PDF)

The novel NSAID-derivative, MCI-030, prevents ovarian cancer in the egg-laying hen by increasing tumor cell apoptosis and decreasing beta-catenin and MAPK oncogenic signaling

Gynecologic oncology, 2021-08, Vol.162, p.S301-S302

2021

Volltextzugriff (PDF)

Abstract B057: Racial disparity research in ovarian cancer: Evaluating race definition in differential gene expression

Cancer epidemiology, biomarkers & prevention, 2020-06, Vol.29 (6_Supplement_1), p.B057-B057

2020

Volltextzugriff (PDF)

1 – 25 von 82

Suche als RSS-Feed

Aktive Filter

KollektionEBSCOhost Business Source Ultimate

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(76)
Mit Volltextzugriff
(80)

Publikationsform

Artikel
(80)
Tagungsberichte
(2)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Expansion of the target of rapamycin (TOR) kinase family and function in Leishmania shows that TOR3 is required for acidocalcisome biogenesis and animal infectivity

Interplay between Immune Checkpoint Proteins and Cellular Metabolism

Regulated expression of the Leishmania major surface virulence factor lipophosphoglycan using conditionally destabilized fusion proteins

ALDH1A1 maintains ovarian cancer stem cell-like properties by altered regulation of cell cycle checkpoint and DNA repair network signaling

Clinicopathologic significance and race-specific prognostic association of MYB overexpression in ovarian cancer

The susceptibility of trypanosomatid pathogens to PI3/mTOR kinase inhibitors affords a new opportunity for drug repurposing

Associations between DNA Damage and PD-L1 Expression in Ovarian Cancer, a Potential Biomarker for Clinical Response

ENTPD1/CD39 as a predictive marker of treatment response to gemogenovatucel-T as maintenance therapy in newly diagnosed ovarian cancer

Immunoregulatory Protein B7-H3 Reprograms Glucose Metabolism in Cancer Cells by ROS-Mediated Stabilization of HIF1α

Analysis of the COVID-19 Vaccine Development Process: an Exploratory Study of Accelerating Factors and Innovative Environments

Unraveling the etiology of ovarian cancer racial disparity in the deep south: Is it nature or nurture?

The Landscape of Neutralizing Monoclonal Antibodies (nAbs) for Treatment and Prevention of COVID-19

Phosphodiesterase 10A is overexpressed in lung tumor cells and inhibitors selectively suppress growth by blocking β-catenin and MAPK signaling

Suppression of Colon Tumorigenesis in Mutant Apc Mice by a Novel PDE10 Inhibitor that Reduces Oncogenic β-Catenin

Phosphodiesterase 10A (PDE10A) as a novel target to suppress β-catenin and RAS signaling in epithelial ovarian cancer

Prospects and Trends in the Brazilian Market for Biologically Sourced Products

Long-Term Follow-Up of Gemogenovatucel-T (Vigil) Survival and Molecular Signals of Immune Response in Recurrent Ovarian Cancer

DNA damage measurements within tissue samples with Repair Assisted Damage Detection (RADD)

Author Correction: ENTPD1/CD39 as a predictive marker of treatment response to gemogenovatucel-T as maintenance therapy in newly diagnosed ovarian cancer

RAD6 promotes DNA repair and stem cell signaling in ovarian cancer and is a promising therapeutic target to prevent and treat acquired chemoresistance

Associations between DNA damage and PDL‐1 expression in ovarian cancer, a potential biomarker for clinical response

Mutagenesis and analysis of genetic mutations in the GC-rich KISS1 receptor sequence identified in humans with reproductive disorders

A plasma-based analysis and genomic landscape of patients with high tumor mutational burden (TMB-H), microsatellite stable (MSS) colorectal cancer (CRC)

The novel NSAID-derivative, MCI-030, prevents ovarian cancer in the egg-laying hen by increasing tumor cell apoptosis and decreasing beta-catenin and MAPK oncogenic signaling

Abstract B057: Racial disparity research in ovarian cancer: Evaluating race definition in differential gene expression

Aktive Filter

Suchergebnisse filtern